Digital Pathology Market, by Application (Chemical Pathology, Hematology, Medical Microbiology, Histopathology), by Offering (Software (Image Analysis Platform(Cloud Based Delivery, On-Premises Delivery), Scanner (Fluorescence Scanner, Bright Field Scanner), Services(Integration and Installation, Consulting Services, Maintenance Services), DPIS(Cloud Based Delivery, On-Premises Delivery)), by Region (Africa, Latin America, Asia Pacific, the Middle East, Europe, and North America), and by End User (Hospitals, Laboratories (Public Laboratories, Research center, Private Laboratories,)- Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030
Digital pathology, also referred to as “virtual microscopy,” is a dynamic image-centered platform that facilitates the capturing, organizing, and analysis of pathology data produced from a scanned glass slide. It has the potential to serve as a diagnostic tool for various infectious and chronic diseases, including hepatic fibrosis, cardiovascular disease, and cancer.
According to projections, the global digital pathology market will be worth US$ 666.0 Mn in 2023 and is anticipated to grow at a CAGR of 7.7% between 2023 and 2030.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/379
The market is anticipated to experience growth during the projected duration due to the rising occurrence of chronic illnesses and the demand for timely detection of these ailments.
The market is anticipated to experience growth in response to the rising occurrence of chronic illnesses and the increasing demand for early detection of such ailments. As an illustration, in 2018, cancer caused 9.6 million deaths and 8.1 million new cases worldwide, as reported by the World Health Organization (WHO). Additionally, in the United States in 2019, cardiovascular disease (CVD) was responsible for 874,613 deaths, and stroke accounted for nearly 1 in 19 deaths. Cerebrovascular disease caused 7.08 million deaths in 2020, with 3.48 million due to ischemic stroke, 0.35 million from subarachnoid hemorrhage, and 3.25 million from intracerebral hemorrhage (ICH).
The global digital pathology market is experiencing growth due to the rising occurrence of infectious diseases.
The global digital pathology market is being driven by the rising prevalence of infectious diseases. For example, the World Health Organization’s July 2018 Factsheet reveals that chronic hepatitis C infection affects approximately 71 million individuals across the world, and nearly 3.99 million deaths occur each year due to hepatitis C, primarily from hepatocellular carcinoma and cirrhosis. The American Heart Association reported that around 1.64 million deaths worldwide were linked to diabetes in 2020, resulting in an age-standardized mortality rate of 20.07 per 100,000. Additionally, the World Heart Federation forecasts that the number of deaths due to Cardiovascular Disease will exceed 23 million annually by 2030. Additionally, as per the Centers for Disease Control and Prevention’s report in 2019, about 18.2 million American adults were diagnosed with coronary artery illness, while nearly 805,000 individuals in the United States suffer from a cardiac arrest annually.
Impact of the Coronavirus (COVID-19) Pandemic
The COVID-19 virus first emerged in December 2019 and has since spread to more than 100 nations worldwide. On January 30, 2020, the World Health Organization announced it a public health emergency.
COVID-19 has three primary ways of impacting the economy, which include direct effects on the demand and production of medical devices and drugs, disturbances in the channels of distribution, and financial effects on companies and financial markets. Nations like India, Egypt, Saudi Arabia, China, the U.A.E., and others are encountering transportation difficulties for medical devices and drugs due to nationwide lockdowns.
The global digital pathology market experienced a favorable effect from the COVID-19 pandemic due to the rising demand for digital pathology in diagnosing COVID-19 in the suspected patients. An example of this is when Leica Bio systems, a biotechnology firm, supplied a digital pathology platform to multiple pathology laboratories in January 2021 for COVID-19 monitoring purposes. Furthermore, the National Center for Biotechnology Information reported in July 2020 that the COVID-19 pandemic has significantly affected regular pathology services. To ensure the continuity of clinical services and pathology-related research in the present circumstances, digital pathology could be employed. This method of diagnosis, which involves evaluating surgical pathology slides from formalin-fixed paraffin-embedded tissue (FFPE), represents a novel approach. However, it could also impact the social interaction among pathologists, including their interactions with patients and clinicians.
Recent Developments
- Hoffmann-La Roche AG, a pharmaceutical firm, partnered with Bristol-Myers Squibb, another pharmaceutical company, in March 2022 to enhance the progress of two clinical trial assays by creating and launching two novel digital pathology algorithms. The initial endeavor in this partnership involves Roche Digital Pathology developing an image analysis algorithm utilizing artificial intelligence that would assist pathologists in interpreting the VENTANA PD-L1 (SP142) Assay currently available in the market. Bristol-Myers Squibb aims to employ this algorithm to produce biomarker data from samples gathered during clinical trials. The second project involves the utilization of F. Hoffmann-La Roche AG’s recently announced open environment collaboration with PathAI, which aims to incorporate a CD8 biomarker analysis algorithm developed by PathAI into the NAVIFY Digital Pathology workflow software.
Market Restraints
The primary obstacles to the expansion of the global digital pathology market are exorbitant expenses related to digital pathology equipment and devices. In March 2019, the National Center for Biotechnology Information reported that the total expense of deploying digital pathology can reach up to US$ 150,000 across the globe. Additional expenditures, including upkeep and training expenses, also contribute to the hindrance.
Competitive Landscape
Leading companies including Sectra ABss, Ventana Medical Systems, Inc., Paige, Perkin Elmer, Inc., Hamamatsu Photonics, K.K., Koninklijke Philips N.V., Definiens AG, GE Healthcare, Leica Biosystems, Inspirata Co., and 3D-Histech Ltd. are operating in the global digital pathology market.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/379
| The market size value in 2023 |
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Digital Pathology Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Digital Pathology Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/379
Explore More Related Insights:
Vital sign monitoring devices market
Body Contouring Devices Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837